- Trials with a EudraCT protocol (18)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
18 result(s) found for: ASA physical status classification system.
Displaying page 1 of 1.
EudraCT Number: 2010-020152-54 | Sponsor Protocol Number: MOLT-2010-01 | Start Date*: 2010-11-17 | |||||||||||
Sponsor Name:MOLTENI | |||||||||||||
Full Title: Pilot double blind study to assess the efficacy and tolerability of morphine sulphate oral solution (Oramorph) given as add-on therapy in the preventive analgesia (pre-medication) in patients under... | |||||||||||||
Medical condition: Add-on therapy in the preemptive analgesia (pre-medication) in patients undergoing laparascopy cholecistectomy. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-001787-36 | Sponsor Protocol Number: ANA-07113G | Start Date*: 2008-11-13 |
Sponsor Name:Universitätsklinikum Mannheim, Universitätsklinik für Anästhesiologie und Operative Intensivmedizin | ||
Full Title: Verbessert die perioperative Applikation von Esketamin in subanästhetischer Dosierung die postoperative Analgesie? | ||
Medical condition: This trial investigates the use of esketamine in subanesthetic dosages in patients undergoing surgery performed under general anaesthesia particularly with regard to quality of postoperative analge... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2012-001557-46 | Sponsor Protocol Number: 01 | Start Date*: 2012-06-27 |
Sponsor Name:Sydvestjysk Sygehus, Esbjerg [...] | ||
Full Title: Perioperativ installation of ropivacain in mastectomy – with or without axillary lymph node dissection after sentinel node diagnostics or known lymph node metastasis – A double-blind, randomized cl... | ||
Medical condition: Unilateral mastectomy with or without axillary lymph node dissection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: DK (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2005-000877-23 | Sponsor Protocol Number: JM/JS/4551 | Start Date*: 2005-04-11 |
Sponsor Name:Oxford Radcliffe Hospitals NHS trust | ||
Full Title: Is Remifentanil better than Propofol in providing optimal conditions for an awake fibreoptic intubation? | ||
Medical condition: Awake fibre optic intubation is an anaesthetic technique used to intubate patients with a difficult to manage airway. It s a procedure by which a tracheal tube is inserted in a patients trachea wh... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-000033-36 | Sponsor Protocol Number: LYMRIT-37-01 | Start Date*: 2012-10-18 | |||||||||||
Sponsor Name:Nordic Nanovector ASA | |||||||||||||
Full Title: A phase I/II study of lutetium (177Lu)-lilotomab satetraxetan (Betalutin®) antibody-radionuclide-conjugate for treatment of relapsed non-Hodgkin lymphoma. | |||||||||||||
Medical condition: Non-Hodgkin B-cell lymphoma Part A: Relapsed indolent Non-Hodgkin B-cell lymphoma Part B: Relapsed follicular lymphoma Part C: Relapsed indolent Non-Hodgkin B-cell lymphoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) GB (GB - no longer in EU/EEA) IT (Prematurely Ended) CZ (Prematurely Ended) AT (Completed) FR (Ongoing) ES (Prematurely Ended) HR (Completed) HU (Completed) IE (Completed) DK (Prematurely Ended) FI (Completed) DE (Completed) NL (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019109-40 | Sponsor Protocol Number: XC0409 | Start Date*: 2011-03-25 | |||||||||||
Sponsor Name:Xenome Ltd | |||||||||||||
Full Title: A multicenter, randomized, observer-blinded, single-dose, placebo-controlled, sequential cohort study of the efficacy and safety of Xen2174 in subjects following bunionectomy surgery | |||||||||||||
Medical condition: Moderate to severe acute post-operative pain in subjects following primary unilateral first metatarsal bunionectomy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-005599-33 | Sponsor Protocol Number: AMSC-BDT-001 | Start Date*: 2013-06-10 | |||||||||||
Sponsor Name:Lékařská fakulta Univerzity Karlovy v Hradci Králové | |||||||||||||
Full Title: Utilization of Autologous Multipotent Mesenchymal Stem Cells in the Management of the Large Skeletal Defects during Revision Total Hip Arthroplasty: a Prospective, Non-randomized, Open-Label Study ... | |||||||||||||
Medical condition: Revision total hip arthroplasty. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000732-22 | Sponsor Protocol Number: OSTAP | Start Date*: 2020-05-18 |
Sponsor Name:Pablo Rama Maceiras | ||
Full Title: Effectiveness comparative study of oblique subcostal transversus abdominis plane block (OSTAP block) versus laparoscopic ports infiltration in patients undergoing elective cholecystectomy. | ||
Medical condition: Elective cholecystectomy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005808-17 | Sponsor Protocol Number: HEEL-2012-04 | Start Date*: 2013-06-11 | ||||||||||||||||
Sponsor Name:Radboud University Medical Centre | ||||||||||||||||||
Full Title: The analgesic efficacy of perioperative Δ9-THC (Namisol®) in patients undergoing major abdominal surgery: a randomized, double blinded, placebo-controlled, parallel design | ||||||||||||||||||
Medical condition: Patients undergoing elective major abdominal surgery | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-005115-26 | Sponsor Protocol Number: SKY0402-C-208 | Start Date*: 2008-01-21 |
Sponsor Name:Pacira Pharmaceuticals Inc. | ||
Full Title: A Multicenter, Randomized, Double-Blind, Parallel-Group, Active-Control, Dose-Ranging Study to Evaluate the Safety, Efficacy, and Comparative Systemic Bioavailability of a Single Administration of ... | ||
Medical condition: post-operative pain management | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) AT (Prematurely Ended) DE (Completed) DK (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2018-003318-42 | Sponsor Protocol Number: TAK-954-2004 | Start Date*: 2019-06-11 | |||||||||||
Sponsor Name:Takeda Development Center Americas, Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of 2 Dose Regimens of Intravenous TAK-954 for the Prophylaxis and Treatment of Postope... | |||||||||||||
Medical condition: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of 2 Dose Regimens of Intravenous TAK-954 for the Prophylaxis and Treatment of Postope... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005216-28 | Sponsor Protocol Number: VNK115640 | Start Date*: 2012-04-05 | |||||||||||
Sponsor Name:GlaxoSmithKline | |||||||||||||
Full Title: A Multicenter, Randomized, Single-blind, Active-controlled, Parallel Group, Phase II Study to Evaluate the Efficacy, Safety, and Tolerability of a Single Intravenous (6 mg, 12 mg, 18 mg, 24 mg or 3... | |||||||||||||
Medical condition: Post-operative nausea and vomiting (PONV) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) GB (Prematurely Ended) PL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004872-17 | Sponsor Protocol Number: IC2020-04 | Start Date*: 2021-03-18 | ||||||||||||||||
Sponsor Name:INSTITUT CURIE | ||||||||||||||||||
Full Title: A Double-blind Randomized non-inferiority Trial of erector spinae block (ESP) versus paravertebral block (PVB) before Breast Cancer Surgery: Effects on acute Postoperative Pain | ||||||||||||||||||
Medical condition: Nervous Block erector spinae plane (ESP) or paravertebral block (PVB) preoperatively in women with breast adenocarcinoma without metastasis or breast in situ adenocarcinoma to by treated either by... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: FR (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-008527-14 | Sponsor Protocol Number: Q8012-001 | Start Date*: 2009-06-02 | ||||||||||||||||
Sponsor Name:University of Witten/Herdecke | ||||||||||||||||||
Full Title: A Randomized, Double-Blind, Active Controlled Study Comparing the Intravenous Dose of Morphine and Oxycodone Combined in a Ratio of 1:1 Versus Morphine Alone Required to Achieve Effective Pain Cont... | ||||||||||||||||||
Medical condition: To determine whether the intravenous coadministration of morphine and oxycodone has fewer opioid related adverse effects (AEs) than morphine alone at doses that result in effective and equi-analges... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000137-14 | Sponsor Protocol Number: PDC-01-0206 | Start Date*: 2021-05-04 | |||||||||||
Sponsor Name:Cessatech A/S | |||||||||||||
Full Title: Pharmacokinetic study of intranasal CT001 in children 1-17 years of age undergoing elective surgical procedures | |||||||||||||
Medical condition: Management of acute pain in children 1-17 years with the objective of preventing pain and distress associated with painful medical procedures in children. | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-020380-20 | Sponsor Protocol Number: R331333-PAI2005/KF5503-59 | Start Date*: 2012-03-09 | |||||||||||
Sponsor Name:Janssen Research & Development, L.L.C. | |||||||||||||
Full Title: Open-Label Evaluation of the Pharmacokinetic Profile and Safety of Tapentadol Oral Solution for the Treatment of Postsurgical Pain in Children and Adolescents Aged From 6 to Less Than 18 Years | |||||||||||||
Medical condition: Pain | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004242-10 | Sponsor Protocol Number: MM1-2020 | Start Date*: 2020-12-21 | |||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Centre for Anaesthesiological Research, Department of Anaesthesiology, Zealand University Hospital, Køge, Denmark | |||||||||||||||||||||||||||||||||||||||||||
Full Title: Does perineural dexamethasone increase the duration of an ulnar nerve block when controlling for systemic effects? A randomised, blinded, placebo-controlled, paired, non-inferiority trial in health... | |||||||||||||||||||||||||||||||||||||||||||
Medical condition: We will not assess a specific medical condition or disease as only healthy volunteers are included. We will assess if perineural dexamethasone increases the duration of a peripheral nerve block (i.... | |||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-006006-27 | Sponsor Protocol Number: 0869-219 | Start Date*: 2012-11-05 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc | |||||||||||||
Full Title: A Phase IIb, Partially-Blinded, Randomized, Active Comparator-Controlled Study to Evaluate the Pharmacokinetics/Pharmacodynamics, Safety, and Tolerability of Aprepitant in Pediatric Patients for th... | |||||||||||||
Medical condition: Post Operative Nausea and Vomiting in surgical patients | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) ES (Completed) CZ (Completed) IT (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.